Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery

Wo zu kaufen (1) Eigenschaften

Gesponsert

Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery

Medimops DE

52.98 EUR

Preis aktualisiert am: 16-04-2026 09:08:39

Siehe Produktangebot

Allgemein

Marke

LAP Lambert Academic Publishing

Eigenschaften

Ähnliche Produkte

Development of Carvedilol Phosphate sustained release tablet: Anti-hypertensive agent:Carvedilol phosphate

Development of Carvedilol Phosphate sustained release tablet: Anti-hypertensive agent:Carvedilol phosphate

Produkt anzeigen

Novel injectable hydrogel: optimized sustained drug release for Spine

Novel injectable hydrogel: optimized sustained drug release for Spine

Produkt anzeigen

LAMOTRIGINE TABLETS: Formulation and In vitro evaluation of Lamotrigine Orally disintegrating tablets and Sustained release tablets

LAMOTRIGINE TABLETS: Formulation and In vitro evaluation of Lamotrigine Orally disintegrating tablets and Sustained release tablets

Produkt anzeigen

Process Optimization of Diclofenac Sodium Sustained Release Tablet: Dosage Form Development

Process Optimization of Diclofenac Sodium Sustained Release Tablet: Dosage Form Development

Produkt anzeigen

Formulation and evaluation of sustained release tablets of w-8019

Formulation and evaluation of sustained release tablets of w-8019

Produkt anzeigen

Thermosensitive In-Situ Hydrogel And Nanosuspensions

Thermosensitive In-Situ Hydrogel And Nanosuspensions

Produkt anzeigen